• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿皮肤肥大细胞增多症:180例患者的综述

Pediatric cutaneous mastocytosis: a review of 180 patients.

作者信息

Ben-Amitai Dan, Metzker Aryeh, Cohen Herman A

机构信息

Schneider Children's Medical Center of Israel, Petah Tiqva, Israel.

出版信息

Isr Med Assoc J. 2005 May;7(5):320-2.

PMID:15909466
Abstract

BACKGROUND

Mastocytosis is a heterogeneous group of diseases characterized by the abnormal infiltration of mast cells in the skin and, sometimes, other organs. Some patients may experience symptoms related to mast cell mediator release.

OBJECTIVE

To analyze the clinical features of cutaneous mastocytosis in a large series of children.

METHODS

We conducted a file review of all children clinically diagnosed with cutaneous mastocytosis in our department over the last 20 years. We evaluated gender, age at onset, character and distribution of the lesions, associated symptoms, and course of the disease.

RESULTS

Altogether, 180 patients with cutaneous mastocytosis were identified. The male to female ratio was 1.5:1. About one-third of patients had a mastocytoma, which was present at birth in over 40% and appeared during the first year of life in most of the remainder. Urticaria pigmentosa was noted in 65% of the patients, presenting at birth in 20% and during the first year in most of the remainder. The majority of lesions was distributed over the trunk and limbs. Different kinds of associated symptoms were noted. Prognosis in general was good. Only 11% of the cases, all urticaria pigmentosa, were familial.

CONCLUSIONS

Most cases of pediatric mastocytosis are sporadic and appear during the first 2 years of life, especially on the trunk. Urticaria pigmentosa is the most frequent variant. The prognosis of pediatric mastocytosis, in general, is good.

摘要

背景

肥大细胞增多症是一组异质性疾病,其特征为肥大细胞在皮肤以及有时在其他器官中异常浸润。一些患者可能会出现与肥大细胞介质释放相关的症状。

目的

分析大量儿童皮肤肥大细胞增多症的临床特征。

方法

我们对过去20年在我科临床诊断为皮肤肥大细胞增多症的所有儿童病历进行了回顾。我们评估了性别、发病年龄、皮损的特征和分布、相关症状以及病程。

结果

共确定了180例皮肤肥大细胞增多症患者。男女比例为1.5:1。约三分之一的患者患有肥大细胞瘤,其中40%以上在出生时即存在,其余大部分在出生后第一年出现。65%的患者有色素性荨麻疹,20%在出生时出现,其余大部分在出生后第一年出现。大多数皮损分布于躯干和四肢。观察到不同类型的相关症状。总体预后良好。仅11%的病例(均为色素性荨麻疹)为家族性。

结论

大多数儿童肥大细胞增多症病例为散发性,在出生后头2年内出现,尤其是在躯干。色素性荨麻疹是最常见的类型。儿童肥大细胞增多症总体预后良好。

相似文献

1
Pediatric cutaneous mastocytosis: a review of 180 patients.小儿皮肤肥大细胞增多症:180例患者的综述
Isr Med Assoc J. 2005 May;7(5):320-2.
2
Cutaneous mastocytosis in children: a clinical analysis of 71 cases.儿童皮肤肥大细胞增多症:71例临床分析
J Eur Acad Dermatol Venereol. 2004 May;18(3):285-90. doi: 10.1111/j.1468-3083.2004.00830.x.
3
Cutaneous mastocytosis: demographic aspects and clinical features of 55 patients.皮肤肥大细胞增多症:55例患者的人口统计学特征和临床特点
J Eur Acad Dermatol Venereol. 2006 Sep;20(8):969-73. doi: 10.1111/j.1468-3083.2006.01696.x.
4
Cutaneous mastocytosis in Thai children.泰国儿童的皮肤肥大细胞增多症。
J Med Assoc Thai. 2008 Oct;91 Suppl 3:S143-6.
5
[Cutaneous mastocytosis].[皮肤肥大细胞增多症]
Rev Prat. 2006 Oct 31;56(16):1745-51.
6
Cutaneous mastocytosis in Singapore.新加坡的皮肤肥大细胞增多症。
Singapore Med J. 1993 Oct;34(5):425-9.
7
Most common clinical presentations of cutaneous mastocytosis.皮肤肥大细胞增多症最常见的临床表现。
Acta Clin Croat. 2009 Mar;48(1):59-64.
8
Cutaneous mastocytosis: a review focusing on the pediatric population.皮肤肥大细胞增多症:聚焦儿科人群的综述
Clin Pediatr (Phila). 2008 Oct;47(8):757-61. doi: 10.1177/0009922808318344. Epub 2008 May 23.
9
Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.血清类胰蛋白酶和SCORMA(肥大细胞增多症评分)指数作为儿童和成人皮肤肥大细胞增多症疾病严重程度参数。
Clin Exp Dermatol. 2009 Jun;34(4):462-8. doi: 10.1111/j.1365-2230.2008.03005.x.
10
Pediatric mastocytosis.小儿肥大细胞增多症
J Invest Dermatol. 1991 Mar;96(3):15S-18S.

引用本文的文献

1
Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients.皮肤肥大细胞增多症:成人及儿童患者的诊断、评估与管理方法
Am J Clin Dermatol. 2025 May 20. doi: 10.1007/s40257-025-00947-7.
2
Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features.肥大细胞增多症表现为由环氧化酶抑制剂引发的与肥大细胞介质释放相关的症状:患病率、临床及实验室特征
Clin Transl Allergy. 2022 Mar;12(3):e12132. doi: 10.1002/clt2.12132.
3
Cutaneous mastocytosis in childhood.
儿童皮肤肥大细胞增多症。
Allergol Select. 2022 Jan 5;6:1-10. doi: 10.5414/ALX02304E. eCollection 2022.
4
Systemic Mastocytosis: Multidisciplinary Approach.系统性肥大细胞增多症:多学科诊疗方法
Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021068. doi: 10.4084/MJHID.2021.068. eCollection 2021.
5
Mastocytosis and Mast Cell Activation Disorders: Clearing the Air.肥大细胞增多症和肥大细胞激活障碍:澄清问题。
Int J Mol Sci. 2021 Oct 19;22(20):11270. doi: 10.3390/ijms222011270.
6
Clinicopathological Profile of Childhood Onset Cutaneous Mastocytosis from a Tertiary Care Center in South India.印度南部一家三级医疗中心儿童期起病的皮肤肥大细胞增多症的临床病理特征
Indian Dermatol Online J. 2021 Sep 10;12(5):706-713. doi: 10.4103/idoj.IDOJ_924_20. eCollection 2021 Sep-Oct.
7
Diffuse cutaneous mastocytosis masquerading as linear IgA bullous dermatosis of childhood.伪装成儿童线状IgA大疱性皮肤病的弥漫性皮肤肥大细胞增多症。
Dermatol Reports. 2021 Mar 17;13(1):9021. doi: 10.4081/dr.2021.9021. eCollection 2021 Mar 18.
8
Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference.首届美国肥大细胞疾病倡议(AIM)研究者会议论文集。
J Allergy Clin Immunol. 2021 Jun;147(6):2043-2052. doi: 10.1016/j.jaci.2021.03.008. Epub 2021 Mar 11.
9
Pediatric Mastocytosis: Recognition and Management.儿童肥大细胞增生症:识别与管理。
Am J Clin Dermatol. 2021 Mar;22(2):205-220. doi: 10.1007/s40257-020-00581-5.
10
How "benign" is cutaneous mastocytosis? A Danish registry-based matched cohort study.皮肤肥大细胞增多症的“良性”程度如何?一项基于丹麦登记处的匹配队列研究。
Int J Womens Dermatol. 2020 Jun 1;6(4):294-300. doi: 10.1016/j.ijwd.2020.05.013. eCollection 2020 Sep.